(ZURN) Zurich Insurance - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0011075394
ZURN: Life, Property, Casualty, Liability, Retirement, Investments
Zurich Insurance Group AG (SW:ZURN) is a global leader in the insurance industry, renowned for its comprehensive range of products and services across multiple regions. With a strong foundation since 1872, the company has established itself as a trusted name, leveraging its expertise in risk management and digital transformation. Its commitment to sustainability and innovation underscores its market position, particularly in emerging markets where it continues to expand.
The companys operations are segmented into Property & Casualty Regions, Life Regions, Farmers, Group Functions and Operations, and Non-Core Businesses. Each segment is strategically managed to cater to diverse market needs, ensuring a balanced and robust portfolio. Zurichs focus on digital transformation is evident in its customer service enhancements and operational efficiencies, aligning with industry trends and customer expectations.
Zurich offers an extensive suite of insurance products, including car, home, and travel insurance, as well as life and critical illness coverage. Additionally, the company provides employee benefit insurance and specialized services like climate resilience and cyber risk assessment. This diverse product range is complemented by innovative solutions, such as tailored risk management strategies, enhancing its appeal to a broad customer base.
The companys distribution network includes agents, brokers, and bancassurance channels, ensuring wide reach and accessibility. This multi-channel approach allows Zurich to serve individuals, SMEs, and multinational corporations effectively, adapting to varying market dynamics and customer needs.
3-Month Forecast: Zurichs stock is expected to trade near its 20-day SMA of 560.95, indicating potential support around the 550 level. Resistance is anticipated at 570, reflecting moderate volatility with an ATR of 13.63. The companys stable financials, with a P/E of 15.41 and RoE of 19.18%, suggest resilience against macroeconomic challenges, positioning it favorably for sustained performance.
Additional Sources for ZURN Stock
ZURN Stock Overview
Market Cap in USD | 96,905m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
ZURN Stock Ratings
Growth Rating | 93.6 |
Fundamental | 49.2 |
Dividend Rating | 79.3 |
Rel. Strength | 13.4 |
Analysts | - |
Fair Price Momentum | 656.99 CHF |
Fair Price DCF | 1156.98 CHF |
ZURN Dividends
Dividend Yield 12m | 5.28% |
Yield on Cost 5y | 12.23% |
Annual Growth 5y | 5.39% |
Payout Consistency | 92.1% |
ZURN Growth Ratios
Growth Correlation 3m | 45.4% |
Growth Correlation 12m | 95.8% |
Growth Correlation 5y | 97.3% |
CAGR 5y | 19.85% |
CAGR/Max DD 5y | 1.30 |
Sharpe Ratio 12m | 2.28 |
Alpha | 26.86 |
Beta | 0.475 |
Volatility | 19.88% |
Current Volume | 237k |
Average Volume 20d | 329.8k |
As of April 26, 2025, the stock is trading at CHF 568.80 with a total of 237,009 shares traded.
Over the past week, the price has changed by +0.78%, over one month by -3.17%, over three months by +9.35% and over the past year by +35.29%.
Partly, yes. Based on ValueRay Fundamental Analyses, Zurich Insurance (SW:ZURN) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.18 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZURN as of April 2025 is 656.99. This means that ZURN is currently undervalued and has a potential upside of +15.5% (Margin of Safety).
Zurich Insurance has no consensus analysts rating.
According to ValueRays Forecast Model, ZURN Zurich Insurance will be worth about 724.7 in April 2026. The stock is currently trading at 568.80. This means that the stock has a potential upside of +27.41%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 544.7 | -4.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 724.7 | 27.4% |